These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 2192107

  • 1. [Clinical significance of YH-206 assay analysis as a tumor marker].
    Yachi A, Hinoda Y, Imai K, Endo T.
    Nihon Rinsho; 1990 Feb; 48 Suppl():1068-70. PubMed ID: 2192107
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical significance of DU-PAN-2 analysis as a tumor marker].
    Sawabu N, Satomura Y.
    Nihon Rinsho; 1990 Feb; 48 Suppl():1003-7. PubMed ID: 2162408
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical significance of pancreatic oncofetal antigen, pancreatic cancer associated antigen assay as tumor markers].
    Shimano T, Morimoto H, Saito M, Mori T.
    Nihon Rinsho; 1990 Feb; 48 Suppl():917-9. PubMed ID: 2192174
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical significance of NCC-ST-439 antigen assay detected by the monoclonal antibody as a tumor marker].
    Sugano K, Okura H.
    Nihon Rinsho; 1990 Feb; 48 Suppl():1031-4. PubMed ID: 2192105
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical significance of TAC-41 assay as a tumor marker].
    Ariyoshi Y, Kuwabara M, Iwakoshi N, Kito K.
    Nihon Rinsho; 1990 Feb; 48 Suppl():1060-3. PubMed ID: 2162412
    [No Abstract] [Full Text] [Related]

  • 7. [CA72-4 (TAG-72)].
    Maida Y, Kyo S, Inoue M.
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():672-4. PubMed ID: 16149608
    [No Abstract] [Full Text] [Related]

  • 8. [Clinical significance of TAG-72 assay as a tumor marker].
    Motoo Y, Sawabu N.
    Nihon Rinsho; 1990 Feb; 48 Suppl():1064-7. PubMed ID: 2355505
    [No Abstract] [Full Text] [Related]

  • 9. [Evaluation of KMO1 for the gastrointestinal disease].
    Okumura S, Ohyanagi H, Saitoh Y.
    Nihon Rinsho; 1990 Feb; 48 Suppl():1017-21. PubMed ID: 2192103
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical significance of CA 195 assay as a tumor marker].
    Ohkura H, Sakawaki T.
    Nihon Rinsho; 1990 Feb; 48 Suppl():982-4. PubMed ID: 2355639
    [No Abstract] [Full Text] [Related]

  • 11. [Clinical significance of CA 50 assay as a tumor marker].
    Hara K, Mitsuhashi F, Ohkura H.
    Nihon Rinsho; 1990 Feb; 48 Suppl():971-3. PubMed ID: 2192182
    [No Abstract] [Full Text] [Related]

  • 12. [Occurrence of pancreatic tumor markers and diagnosis of small pancreatic tumors. 6). Application of tumor marker KM 01 analysis in the diagnosis of pancreatic neoplasms].
    Okumura S, Ohyanagi H, Saito Y.
    Nihon Rinsho; 1986 Aug; 44(8):1834-42. PubMed ID: 3537375
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical significance of Span-1 antigen assay as a tumor marker].
    Satake K, Chung YS, Umeyama K.
    Nihon Rinsho; 1990 Feb; 48 Suppl():1053-6. PubMed ID: 2355504
    [No Abstract] [Full Text] [Related]

  • 14. [Tumor markers in hepatoma, gallbladder-biliary tract and pancreas cancer].
    Nakahara M, Fujisawa K.
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3010-9. PubMed ID: 2445292
    [Abstract] [Full Text] [Related]

  • 15. The carbohydrate antigenic determinant 19-9 (CA 19-9): a monoclonal antibody defined tumor marker.
    DelVillano BC, Zurawski VR.
    Lab Res Methods Biol Med; 1983 Nov; 8():269-82. PubMed ID: 6196588
    [No Abstract] [Full Text] [Related]

  • 16. [Tumor markers for pancreatic and biliary tract cancer].
    Takezako Y, Okusaka T, Ueno H, Ikeda M, Morizane C, Najima M.
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1443-6. PubMed ID: 15446574
    [Abstract] [Full Text] [Related]

  • 17. Analysis of monoclonal antibodies for identification of antigens associated with tumours of the gastrointestinal tract.
    Yang GY, Price MR.
    Anticancer Res; 1989 Sep; 9(6):1707-12. PubMed ID: 2697185
    [Abstract] [Full Text] [Related]

  • 18. Detection of a circulating tumor-associated antigen with a murine monoclonal antibody, LISA 101, selected by reversed indirect enzyme-linked immunosorbent assay.
    Kohno N, Kyoizumi S, Tanabe M, Oyama T, Vossler M, Yamakido M, Akiyama M.
    Cancer Res; 1989 Jun 15; 49(12):3412-9. PubMed ID: 2655895
    [Abstract] [Full Text] [Related]

  • 19. [CA 19-9, a new tumor marker].
    Akai S.
    Rinsho Byori; 1983 Dec 15; 31(12):1300-2. PubMed ID: 6587136
    [No Abstract] [Full Text] [Related]

  • 20. [Pancreatic cancer and tumor markers].
    Watanabe H, Kawakami H, Yamakawa O, Satomura Y, Ohta H, Motoo Y, Okai T, Sawabu N.
    Rinsho Byori; 1991 Jun 15; Suppl 89():58-72. PubMed ID: 1680205
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.